Clinical Trial Update: FDG-PET Scan Response Guided Chemotherapy Strategy for Advanced Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A phase 2 clinical trial update describing a PET-guided chemotherapy strategy for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Asan Medical Center | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN